Market Analysis - (2019) Volume 5, Issue 2
Prime Health Care Group, UAE Latifa Hospital, UAE, E-mail: amr0106@gmail.com
Hilaris Infectious Diseases and Control 2020 welcomes you all the Keynote Speakers, Plenary Speakers, Delegates, Poster presenters, Exhibitors, Industrialists, entrepreneurs, Young Researchers, students, Practitioners.
We are hosting an international conference on Infectious Diseases and Control on October 07-08, 2020 in Zurich, Switzerland. We have introduced a theme “Identifying the Various Infectious Diseases and the ways to control”. We truly believe in learning a new aspects in a day will change your entire life.
Learning is a never-ending process. We at Hilaris Conferences will provide a unique platform for the learners, researchers, policymakers, and innovators to network and share knowledge. Hilaris Conferences will act as a bridge between the Academia & Industry to fill the knowledge gap and inspire young minds through its unique learning opportunities. We will offer a huge opportunity to share creative ideas, and promote the collaborative research environment through its specially designed networking sessions for a challenging future. We established a strong base for researchers and learners in the journey of their lifelong quest for knowledge.
Infectious diseases continue to be a major problem in United States of America, and developments in medical technology have sometimes, paradoxically, contributed to the issue. Although the spotlight has shifted over time from infectious diseases to the chronic, non-infectious diseases that develop in the course of ageing, infectious diseases are still an important cause of illness and death worldwide. In addition to the predictable burden of endemic diseases such as Candida and dengue, the threat of pandemics is ever-present and global, and Europe and USA have not been spared from this onslaught. This issue highlights articles on the threat of the Zika virus (ZIKV) in the new-born, neurological sequelae of enteroviruses in children and prognostic factors influencing the mortality risk of candidaemia in intensive care unit patients. They contribute to the body of research as the fight against emerging and re-emerging infectious diseases continues into a new era.
Enterovirus infection is another common, endemic infectious disease in USA with occasional large outbreaks. The cause of the well-known HFMD, enterovirus infection may have severe neurological sequelae in children. Taking into account the lack of previous studies on neurological manifestations, though all articles reviewed the clinical virology of enteroviruses in New York children. But the casecontrol study was performed in a single centre and included 48 children with confirmed enterovirus infection. A high percentage (75%) of the patients had neurological manifestations, mostly aseptic meningitis. An unfortunate finding was that long-term neurological sequelae were seen in 16.7% of the patients. This study underscores the need to evaluate for neurological involvement in children with this Scommon infection.
Infectious diseases remain a major burden for mortality and morbidity in Singapore and the rest of Asia. There is a need to be vigilant for pandemics such as ZIKV and SARS. At the same time, we need to manage ongoing endemic diseases such as enteroviruses and dengue, and control diseases contributed by improving medical technologies, such as candidaemia. More research needs to be done in these areas to prevent these infectious diseases and improve clinical care.
The market for infectious disease molecular diagnostics tests incorporates reference research centers, hospitals, blood banks. Size is predicted to grow at 9.42% CAGR from 2018 to 2023 and it is determined that the Middle East and Africa market was valued at USD 1.35 billion in 2018 and is depended upon to accomplish USD 2.12 billion by 2023. Diagnostics of the Infectious disease includes a different technique to check for the presence of a foreign antigen/organism with the assistance of numerous diagnostic tools. Conditions of the Infectious disease are highly widespread in underdeveloped regions due to the lack of awareness for individual cleanliness, minimal health care expenditures, and absence of effective physician services. Rising instances of infectious diseases in developed economies are additionally expected to help the market development. This has resulted in vitro diagnostic gadget makers to invest in emerging countries. These organizations are making efforts to develop and popularize cost-effective tools for the diagnosis of infectious diseases.
The global IVD infectious diseases market size was valued at USD 18.8 billion in 2018. It is likely to exhibit a CAGR of 6.7% from 2018 to 2026. Increasing external funding for research and development (R&D) activities and proactive government initiatives are among the primary growth stimulants for the market.
Disease diagnostics are utilized for are utilized for in form of a quick, precise test result. Disease diagnostics are on a rise even if it is time-consuming. The infectious disease epidemics are spreading around the world, thereby increasing the demand for diagnostic tests. Additionally, the occurrence of AIDS, malaria, and other diseases are also on increase, creating a vigorous demand for infectious disease diagnostics. Many government-financed programs all over the globe are progressively providing free screening and tests in order to increase awareness, precisely diagnose diseases, and limit the chances of infection. Such activities are foreseen to help the market development in the following couple of years.
However, diagnostic kits are highly priced, and manufacturers still have a poor assortment channel for working across emerging economies. These two components are anticipated to be the key difficulties to rapid revenue growth of the global infectious diseases diagnostics market.
Contact Details:
Anwen Rosella | Program Manager
Infectious Diseases 2020
Contact: infectiousdiseases@hilarisconferences.net
Phone No.: +44 2037690972 (extn 5089)
WhatsApp No.: +81-3-4571-1704
